Univ Paul Valéry Montpellier 3, EPSYLON EA 4556, Montpellier, France.
University Department of Adult Psychiatry, CHU Montpellier, Montpellier, France.
Eur Arch Psychiatry Clin Neurosci. 2023 Mar;273(2):511-515. doi: 10.1007/s00406-022-01413-9. Epub 2022 Apr 30.
Recent evidence suggests that people with schizophrenia are at high risk for severe COVID-19 and should be prioritized for vaccination. However, impaired decision-making capacities could negatively affect the uptake of COVID-19 vaccination in this population. Capacity to consent to COVID-19 vaccination was assessed in 80 outpatients with schizophrenia. Using the MacArthur Competence Assessment Tool for Treatment, 56.3% of the sample were classified as having diminished capacity to consent to the vaccination. Diminished capacity to consent to COVID-19 vaccination was associated with lower vaccination rates, poorer cognition and higher level of psychotic symptoms. Developing interventions for enhancing informed consent for vaccination is urgent within this population.
最近的证据表明，精神分裂症患者患严重 COVID-19 的风险很高，应优先接种疫苗。然而，决策能力受损可能会对该人群接种 COVID-19 疫苗的意愿产生负面影响。本研究评估了 80 名精神分裂症门诊患者对 COVID-19 疫苗接种的同意能力。使用麦克阿瑟治疗决策能力评估工具，样本中有 56.3%的人被归类为同意接种疫苗的能力下降。同意 COVID-19 疫苗接种的能力下降与较低的疫苗接种率、较差的认知能力和更高水平的精神病症状相关。在该人群中，迫切需要制定干预措施来增强对疫苗接种的知情同意。
